Background: The concept of boosting emerged from the field of machine learning. The basic
idea is to boost the accuracy of a weak classifying tool by combining various instances into a …

Breast cancer incidence is increasing worldwide, and breast cancer-related mortality is
highest in women of African ancestry, who are more likely to have basal-like or triple …

There are limited therapeutic methods for triple negative breast cancer in the clinic, which is
easy to progress into the brain to form metastatic lesions and evolve into the terminal stage …

The molecular inversion probe (MIP) assay technology was originally developed for single
nucleotide polymorphism (SNP) genotyping, but has subsequently been used for identifying …

Glycometabolism is a distinctive aspect of energy metabolism in breast cancer, and key
glycometabolism enzymes/pathways (glycolysis, hexosamine biosynthetic pathway, and …

Background Breast cancer patients who are resistant to neoadjuvant chemotherapy
(NeoCT) have a poor prognosis. There is a pressing need to develop in vivo models of …

Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive ductal carcinoma
(IDC). Annotation of the genetic differences between the two lesions may assist in the …

Purpose: Low molecular weight cyclin E (LMW-E) detected by Western blot analysis predicts
for reduced breast cancer survival; however, it is impractical for clinical use. LMW-E lacks a …

Simple Summary Circulating tumor cells (CTCs) are crucial for the identification of patients
with a higher risk of relapse, including those diagnosed with breast cancer (BC). The aim of …

Cyclin E and its co-activator, phospho–cyclin-dependent kinase 2 (p-CDK2), regulate G 1 to
S phase transition and their deregulation induces oncogenesis. Immunohistochemical …